Chesapeake Urology Associates

(866) 953-3111

Page Options

Bladder Cancer

If you have been diagnosed with recurrent high grade bladder cancer, you may qualify for this research study.

A Phase 3, Randomized, Active-Controlled Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348 (MCC) as compared with Mitomycin C in the Intravesical Treatment of Subjects with BCG Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Research Locations:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
410-825-6310
Contact Debi Robertson, drobertson@cua.md or 443.471.5873

Glen Burnie/Landmark
806 Landmark Drive, Suite 118
Glen Burnie, MD 21061
410-760-9400
Contact Virginia Michaels, vmichaels@cua.md or 443.471.5753

Franklin Square/White Marsh
6830 Hospital Drive, Suite 204
Baltimore, MD 21237
410-391-6131
Contact Angela Somers, asomers@cua.md or 443.471.5829

For additional information go to: www.endo.com

« Current Clinical Trials

Erectile Dysfunction (ED)

Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)

Peyronies

Kidney Stones

Bladder Cancer

Prostate Cancer

Overactive Bladder